News
Two companies with falling promoter pledges are drawing investor interest—one in healthcare expanding aggressively, and the ...
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to a new gene therapy for Amyotrophic Lateral ...
A team at the Peter Mac is planning for first-in-human trials in five years, hoping this new therapy will eschew the ...
Cis-regulatory elements (CREs)—including promoters, enhancers, silencers, and insulators—are critical non-coding DNA ...
Asianet Newsable on MSN5d
Klotho Neurosciences Stock Jumps As FDA Grants Orphan Drug Tag To ALS Gene TherapyThe FDA’s Orphan Drug Designation offers incentives like seven years of U.S. market exclusivity, tax credits for clinical ...
InvestorsHub on MSN6d
Klotho Neurosciences Shares Jump as FDA Grants Orphan Drug Status for ALS TherapyShares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) surged 22% following news that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s gene therapy ...
The U.S. FDA has granted orphan drug designation to Klotho Neurosciences Inc.’s secreted-Klotho (s-KL) promoter, gene and ...
This study demonstrates that Setd2 overexpression rescues bivalent gene expression during zygotic genome activation (ZGA) in ...
Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...
Tomato development relies on intricate gene regulation, with one of the key genes, SlHAM4, emerging as a critical factor in shoot and fruit growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback